Location:
Dept. of Urology
Hospital Universitario de Getafe
Carretera Madrid Toledo Km, 12,5
28905 GETAFE (Madrid)
Spain
Dept. of Urology
Hospital Universitario Infanta Cristina
C/Maestro Amadeo Vives 2 y 3
28009 PARLA (Madrid)
Spain
Dept. of Urology
Hospital Universitario de Fuenlabrada
Camino del Molino 2
28942 FUENLABRADA (Madrid)
Spain
Contact address:
Dr. M.Luján
Hospital Universitario Infanta Cristina
Dept. of Urology
C/Maestro Amadeo Vives 2 y 3
28009 PARLA (Madrid)
Spain
E-mail: mlujang@salud.madrid.org
Dr. A.Páez
Dept. of Urology
Hospital Universitario de Fuenlabrada
Camino del Molino 2
28942 FUENLABRADA (Madrid)
Spain
E-mail: apaez.hflr@salud.madrid.org
Local ERSPC protocol foresees:
- Upon mail invitation (males 45-70 years old) randomization 1:1 to active screening or to control in the active screening arm PSA determination.
- PSA <3 ng/ml: return to screening after 4 years.
- PSA >=3: DRE + US-guided transrectal sextant biopsy plus directed biopsy to DRE/TRUS abnormalities.
- Since 1997, more than 4,000 men were randomised.
- Two additional screening rounds were further completed.
- Since 2009 University Hospitals Infanta Cristina (Madrid, Spain) and Fuenlabrada (Madrid, Spain) are part of the project.
- Local topics of interest:
o performance of PSA-testing outside the screening trial
o performance of TRUS staging
o performance of molecular staging in clinically confined prostate cancer
o PSA-contamination
o all-causes mortality
o nerve-sparing laparoscopic prostatectomy